Concerning the spectrum of IDH-mutant gliomas, diagnosis of an IDH-mutant astrocytoma requires histopathological findings consistent with an infiltrating diffuse glioma with an IDH1/IDH2 mutation and ATRX loss/mutation or exclusion of 1p/19q codeletion. Here, IDH1 is linked to central nervous system cancer.